- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 179.76M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 202.7M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 198.2M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $42M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $3.3M |
| Capex | Q1 2026 · Mar 31, 2026 | $7M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $7.8M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$169M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$85.2M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $152.9M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $650.7M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $44.1M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $44.7M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $499.5M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $903.2M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $317M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.12B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.07B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2.43B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $2.41B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $713.6M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.37B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.63B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.94B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.18B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.29B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.47 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.51 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $173.3M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $164.6M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $15.2M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $15.9M |
| Net Income | Q1 2026 · Mar 31, 2026 | $93.1M |
| Net Income | Q1 2026 · Mar 31, 2025 | $2.1M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $138.2M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $103.1M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $326.7M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $283.6M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $360.8M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $346M |
| Revenue | Q1 2026 · Mar 31, 2026 | $687.5M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $629.6M |